Selling cardiometabolic solutions to employers, payers, and health systems requires reaching skeptical, over-pitched buyers who have long committees and genuine clinical scrutiny. A generic SDR playbook borrowed from B2B SaaS does not work here. We build a sales development motion aligned with how these buyers truly evaluate – the right targets, credible messaging, and a qualification standard that protects your closers' time.
The Challenge
Your SDRs use a generic script to pitch an oversaturated buyer
Benefits leaders and payer medical directors are flooded with cardiometabolic vendor outreach, and a templated cold email lands in the same mental trash bin as the last fifty. Without a message rooted in the buyer's specific cost or clinical problem, your SDRs get ignored no matter how many emails they send. In this category volume without relevance actively trains buyers to tune you out. The motion has to lead with a credible, specific point of view, not a spray-and-pray sequence.
You are pursuing the wrong people within a long, multi-stakeholder committee
Cardiometabolic deals involve benefits, finance, clinical, and sometimes broker stakeholders, and an SDR booking a meeting with the wrong contact wastes the cycle. Generic account lists and title-based targeting miss how these organizations actually decide. In a category with long sales cycles, targeting the wrong entry point can cost a quarter. Sales development has to map the real buying committee and find the entry point that leads somewhere.
Your SDRs lack credibility with a skeptical, clinical buyer
When a benefits leader or clinician asks a pointed question about outcomes or evidence, an SDR running a SaaS script has nothing credible to say, and the conversation dies. Cardiometabolic buyers screen hard for substance because they have been burned by hype. An SDR who cannot hold a credible first conversation burns the opportunity and the account. The motion needs enablement that lets a development rep sound like they understand the buyer's world.
Meetings are booked but remain unqualified, leaving your closers to waste cycles
An SDR compensated on raw meetings will book anyone who says yes, flooding your account executives with unqualified conversations that go nowhere. In a category where each real opportunity is high-value and each sales cycle is long, that wasted closer time is expensive. Without a clear qualification bar, the pipeline looks full and converts poorly. Sales development has to be measured on qualified pipeline, not meeting count, or it quietly destroys value.
How We Can Help
We begin by defining the target and buying committee, rather than starting with a contact list. We identify which employers, payers, or health systems fit your product and how each one actually purchases – who initiates, who conducts the clinical evaluation, who controls the budget – so outreach reaches the entry point most likely to lead to a deal. In cardiometabolic sales, the committee is the targeting unit, and getting that right is most of the battle.
Next, we develop messaging grounded in the buyer's problem. We shape outreach around the specific cost, clinical, or outcome challenge each buyer type faces, using a credible perspective instead of a feature pitch. In a saturated category, that relevance is what generates a reply, and it comes from your actual evidence and positioning, not repurposed SaaS templates.
We then prepare reps to lead a credible first conversation. We equip the development team with clinical context, objection handling, and talk tracks that help them demonstrate an understanding of a benefits leader's or clinician's world. A qualified meeting begins with a rep who can handle the first skeptical question, making enablement essential rather than optional.
For execution, we build and operate the motion – sequences, cadences, channel mix, and routing between development and closing reps – while establishing a clear qualification threshold so only genuine opportunities reach your account executives. Compensation and measurement are based on qualified pipeline, not raw meetings, keeping incentives focused on value. We operate within your current sales stack and process instead of adding a parallel system.
For measurement, we monitor qualified pipeline generated, meeting-to-opportunity conversion, and downstream win rate for SDR-sourced deals. We assess whether meetings booked by your reps truly progress, then refine targeting and messaging according to what converts. A packed calendar that fails to convert is an outcome we intentionally design against.
What sets us apart is that we operate sales development as embedded operators who know cardiometabolic buyers and connect the motion to genuine pipeline – not as a lead-gen provider booking meetings for a fee. In a category this skeptical and committee-driven, an outsourced dialer does not work; building a credible, qualified motion is precisely what we do.
What we deliver
- Target and buying-committee map – which accounts fit and how each employer, payer, or health system actually decides
- Problem-rooted outreach messaging built from your evidence and positioning, not borrowed SaaS templates
- Rep enablement – clinical context, objection handling, and talk tracks to survive a skeptical first conversation
- Built and operated SDR motion – sequences, channel mix, routing, and a qualification bar that protects closers
- Pipeline-based measurement – qualified pipeline created, meeting-to-opportunity conversion, and win rate on sourced deals
In cardiometabolic sales, targeting centers on the buying committee, not an individual contact. When an SDR books the wrong stakeholder using a generic pitch, they do more than miss – in a category this saturated, they teach a high-value buyer to tune you out for the next year.
Our Methodology
We operate sales development through a 90-day sprint. The first 30 days focus on targeting and messaging: we identify fit accounts and map their buying committees, develop problem-rooted outreach, and build rep enablement. Days 30 to 60 focus on launching and iterating: we implement sequences and cadences, define the qualification threshold and routing, and conduct live outreach while refining messaging and targeting based on what generates qualified replies. Days 60 to 90 focus on optimization: we analyze meeting-to-opportunity conversion and downstream win rate, eliminate what does not convert, and leave you with a documented, repeatable motion.
Unlike a lead-gen shop, we know how cardiometabolic buyers truly evaluate, and we connect the motion to qualified pipeline rather than raw meeting volume. An outsourced dialer using a generic script cannot hold up against a skeptical benefits leader or clinical medical director. We embed credibility in both the reps and messaging, measure pipeline and win rate, and guard against the full-but-empty calendar created by meeting-count incentives.
Our Approach
The first 30 days focus on targeting and enablement. We identify the fit accounts and map their actual buying committees, develop problem-rooted messaging, and equip reps with the clinical context and talk tracks required. You will receive a defined target list and messaging your team feels confident bringing into a skeptical conversation.
Days 30 to 60 center on launch and iteration. We implement the sequences, establish the qualification standard and routing between development and closing reps, and conduct live outreach while optimizing around what produces qualified replies. We collaborate closely with your sales leadership because qualification and routing must align with how your closers operate. From your team, we need access to your sales stack, AEs, evidence, and positioning.
Days 60 to 90 cover optimization and handoff. We evaluate meeting-to-opportunity conversion and downstream win rate, sharpen the targeting and messaging, and deliver a documented, repeatable motion. Most engagements last three to six months, with extensions when scaling the motion across new buyer segments, such as an initial payer or health-system push.
Our cadence includes a weekly working session with your sales leadership, along with async pipeline updates. We remain embedded in the sales motion and pipeline data instead of booking meetings externally, keeping the motion focused on qualified pipeline rather than vanity meeting totals.
- Qualified pipeline created
- Meeting-to-opportunity conversion
- Win rate on SDR-sourced deals
- Repeatable, documented development motion
If your diabetes & cardiometabolic health company needs sales development (sdr/bdr) leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a sales development engagement cost for cardiometabolic health and diabetes companies?
We structure sales development as a fixed monthly fee across a three-to-six-month sprint to build and run the motion. The range varies based on the number of buyer segments targeted and whether we are enabling your current reps or creating the motion from the ground up. Unlike an outsourced lead-gen shop compensated per meeting, our model is tied to qualified pipeline, aligning incentives with value rather than volume.
How soon will we see results from a sales development engagement?
Within the first 30 days, targeting, messaging, and enablement will be ready, with live meetings beginning to book soon after launch. Since cardiometabolic sales cycles are lengthy, downstream win-rate signals require at least a full cycle to assess, so we first monitor qualified-meeting and meeting-to-opportunity conversion.
How does the sales development team work with our current staff?
We work as an embedded partner to your sales leadership and account executives because qualification standards and routing must match how your closers operate. We require access to your sales stack, your AEs for feedback and enablement, and your evidence and positioning so we can develop credible messaging.
How is Winston Francois different from a conventional lead-gen provider or outsourced SDR shop?
A lead-gen shop uses a generic dialer and gets paid per meeting, overwhelming your closers with unqualified conversations while teaching skeptical buyers to tune you out. We know how cardiometabolic buyers assess solutions, embed credibility in the reps and messaging, and measure performance through qualified pipeline and win rate.
How is ROI measured for a sales development engagement?
We track qualified pipeline generated, meeting-to-opportunity conversion, and the win rate of deals sourced by the motion. We intentionally avoid rewarding raw meeting totals because unqualified meetings erode closer capacity in this category. We benchmark results against your pipeline generation before the engagement, making the improvement tangible. Since every genuine cardiometabolic opportunity carries high value, even a moderate increase in qualified pipeline can justify the engagement.
What kind of diabetes and cardiometabolic health company is best suited to this service?
This service is designed for companies with roughly 5M to 100M in ARR that sell to employers, payers, or health systems and have account executives prepared to pursue qualified pipeline. It performs best when credible outreach can be built on real evidence and positioning. If you are pre-product-market-fit or offer a purely self-serve motion, sales development is probably too early. The first step is a strategy call with us to map your target accounts and understand how they actually purchase.
